SEC Company Response from Outlook Therapeutics, (OTLK) — Apr 9, 2019
Outlook Therapeutics, Inc.
Date: April 9, 2019 · CIK: 0001649989 · Accession: 0001144204-19-018751
AI Filing Summary & Sentiment
File numbers found in text: 333-229761
Letter
Oppenheimer & Co. Inc.
85 Broad Street
New York, NY 10004
April 9, 2019
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
Re: Outlook Therapeutics, Inc. (the “Company”)
Registration Statement on Form S-1 (File No. 333-229761)
Ladies and Gentlemen:
In connection with the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Oppenheimer & Co. Inc., as the representative of the underwriters, hereby joins in the request of the Company that the effective date of such registration statement be accelerated to 5:00 p.m. (New York time) on April 9, 2019, or as soon thereafter as practicable.
In making this request the undersigned acknowledges that the underwriters are aware of their obligations under the Act as they relate to the public offering of securities pursuant to the registration statement.
[Signature Page Follows]
Very truly yours,
OPPENHEIMER & CO.
INC.
Show Raw Text
CORRESP
1
filename1.htm
Oppenheimer & Co. Inc.
85 Broad Street
New York, NY 10004
April 9, 2019
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jeffrey Gabor
Re: Outlook Therapeutics,
Inc. (the “Company”)
Registration Statement on Form S-1 (File No. 333-229761)
Ladies and Gentlemen:
In connection with
the above-captioned registration statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”),
Oppenheimer & Co. Inc., as the representative of the underwriters, hereby joins in the request of the Company that the effective
date of such registration statement be accelerated to 5:00 p.m. (New York time) on April 9, 2019, or as soon thereafter as practicable.
In making this request
the undersigned acknowledges that the underwriters are aware of their obligations under the Act as they relate to the public offering
of securities pursuant to the registration statement.
[Signature Page
Follows]
Very truly yours,
OPPENHEIMER & CO.
INC.
As the Representative of the Underwriters
By:
/s/ Eric Helenek
Name:
Eric Helenek
Title:
Managing Director